Avalo Therapeutics prices $375 million public offering at $17.75 per share May 5, 2026 11:34PM
Avalo Therapeutics Announces Pricing of $375 Million Public Offering May 5, 2026 11:33PM
Avalo Therapeutics names Taylor Boyd chief business officer Oct 1, 2025 07:00AM
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources Oct 1, 2025 07:00AM
Cantor Fitzgerald Starts Avalo Therapeutics Inc. (AVTX) at Overweight Aug 15, 2025 06:10AM


Nov 7, 2022 09:55AM Avalo Therapeutics Inc. (AVTX) PT Raised to $10 at Cantor Fitzgerald
Mar 2, 2022 10:56AM Cantor Fitzgerald Reiterates Avalo (AVTX) at Overweight, Peak Sales Potential of Pipeline is Underappreciated